Boontil CV 500mg/125mg Tablet
strip of 6.0 tablets.Prescription required
About this product:
| Salt Composition: | Cefuroxime (500mg) + Clavulanic Acid (125mg) |
| Manufacturer: | Mediboon Pharma Private Limited |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Boontil CV 500mg/125mg Tablet is a combination medicine that is used to treat various types of bacterial infections. It fights against the microorganisms to prevent their growth and further spread of the infection. Boontil CV 500mg/125mg Tablet is a prescription medicine. It is advised to take it as per the prescription. It can be taken with or without food but it must be taken at a fixed time to ensure better efficacy. Do not consume more than the recommended dose as this may have harmful effects on your body. If you miss a dose, take it as soon as you remember. The course of the treatment must be completed even if you feel better. Sudden discontinuation of the treatment may affect the potency of the medicine.
Boontil CV 500mg/125mg Tablet is a combination of two medicines: Cefuroxime and Clavulanic Acid. Cefuroxime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria in the human body. Clavulanic Acid is a beta-lactamase inhibitor which blocks the action of enzymes produced by bacteria to inactivate Cefuroxime. Addition of Clavulanic Acid reduces resistance and enhances the activity of Cefuroxime against bacteria.
Can Boontil CV 500mg/125mg Tablet be used to treat viral infections?
No, Boontil CV 500mg/125mg Tablet is specifically designed for treating bacterial infections and should not be used to treat viral infections such as the common cold or flu.
What are the contraindications associated with using Boontil CV 500mg/125mg Tablet?
The use of Boontil CV 500mg/125mg Tablet is contraindicated in patients who have a known allergy to any of its constituents. It is essential to inform your doctor about your medical history before taking this medicine to avoid potential side effects.
Can the use of Boontil CV 500mg/125mg Tablet cause diarrhea?
Yes, the use of Boontil CV 500mg/125mg Tablet may lead to diarrhea due to its antibiotic nature, which can kill beneficial bacteria in your stomach. If you experience persistent diarrhea, it is crucial to drink plenty of water or other fluids and consult your doctor for further guidance.
Can I stop taking Boontil CV 500mg/125mg Tablet when I feel better?
No, it's essential not to discontinue using Boontil CV 500mg/125mg Tablet prematurely. Complete the full course of treatment even if you experience an improvement in symptoms, as this ensures that the infection is fully cured.
What are the instructions for storing and disposing of Boontil CV 500mg/125mg Tablet?
Store Boontil CV 500mg/125mg Tablet in its original packaging, tightly closed. Dispose of any unused medicine responsibly to prevent accidental consumption by children, pets, or others.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Boontil CV 500mg/125mg Tablet may be taken with or without food but it is better to take it at a fixed time.
- Do not use leftover medicine for treating any infection in the future. Always consult your doctor before taking any antibiotic.
- Stop taking Boontil CV 500mg/125mg Tablet and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it.
Alcohol
Consuming alcohol with Boontil CV 500mg/125mg Tablet does not cause any harmful side effects.
Breastfeed
Boontil CV 500mg/125mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Pregnancy
Boontil CV 500mg/125mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
